Related Experiment Video
Updated: Aug 21, 2025
07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
7.7K
The mobile sleep medicine model in neurologic practice: Rationale and application
Mark I Boulos1,2,3, Luqi Chi4, Oleg Y Chernyshev5,6
1Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Frontiers in Neurology
|November 17, 2022
Summary
Undiagnosed obstructive sleep apnea (OSA) significantly impacts neurological patients. An integrated Mobile Sleep Medicine (iMSM) model improves access to screening, testing, and treatment for better patient outcomes.
Area of Science:
- Neurology
- Sleep Medicine
- Public Health
Background:
- Undiagnosed obstructive sleep apnea (OSA) is common in neurology patients, increasing morbidity and mortality.
- OSA causes neurocognitive, cardiovascular, and cerebrovascular impairments, affecting sleep quality.
- Limited access to sleep medicine care hinders timely OSA treatment and risk reduction.
Purpose of the Study:
- To highlight the importance of systematic OSA and hypoventilation/hypoxemia syndromes (HHS) management in neurological conditions.
- To introduce and justify the integrated Mobile Sleep Medicine (iMSM) care model.
- To demonstrate iMSM's utility in neurological practice for OSA and HHS screening, testing, and management.
Main Methods:
- Discussion of systematic screening, testing, and management protocols for OSA and HHS.
- Introduction of the iMSM model, featuring a Mobile Sleep Medicine Unit.
- Description of the three-level operational protocol for iMSM.
Main Results:
- The iMSM model is designed as a patient-centered, outcome-based program.
- iMSM aims to enhance access to OSA management across all healthcare levels.
- The model facilitates efficient screening, timely testing, and coordinated follow-up care.
Conclusions:
- The iMSM model offers an innovative approach to patient-centered sleep medicine care.
- Adoption of the iMSM model can benefit all stakeholders in clinical sleep medicine services.
- iMSM improves access and efficiency in managing OSA and related conditions in neurological practice.
Keywords:
ambulatory sleep testingcognitive impairmenthome sleep apnea test (HSAT)mobile sleep medicineneuromuscular conditionsscreeningsleep-disordered breathingstrokeMore Related Videos
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
5.4K
08:58Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice
Published on: June 19, 2019
9.8K
Related Concept Videos
01:19Management of Insomnia
307
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
307
01:24Sleep-Wake Cycles
1.5K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.5K
01:17Sleepwalking and Sleep Talking
264
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
264
01:15REM Sleep Behavior Disorder
336
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
336
01:07Narcolepsy
179
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
179
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
226
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
226